Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence.
作者信息
Chauhan Aman, Kohn Elise, Del Rivero Jaydira
机构信息
Division of Medical Oncology, Department of Internal Medicine, University of Kentucky, Lexington.
Neuroendocrine and Gynecologic Cancer Therapeutics, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
出版信息
JAMA Oncol. 2020 Jan 1;6(1):21-22. doi: 10.1001/jamaoncol.2019.4568.
Abstract
摘要
相似文献
1
Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence.神经内分泌肿瘤——鲜为人知、常被误解且发病率迅速上升。
JAMA Oncol. 2020 Jan 1;6(1):21-22. doi: 10.1001/jamaoncol.2019.4568.
2
Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry.神经内分泌肿瘤的分布、发病率和预后：癌症登记处的一项基于人群的研究。
Pathol Oncol Res. 2011 Sep;17(3):759-63. doi: 10.1007/s12253-011-9382-y. Epub 2011 Apr 9.
3
Clinical Presentation and Diagnosis of Pancreatic Neuroendocrine Tumors.胰腺神经内分泌肿瘤的临床表现与诊断
Surg Oncol Clin N Am. 2016 Apr;25(2):363-74. doi: 10.1016/j.soc.2015.12.003. Epub 2016 Feb 18.
4
Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops.原发性小肠神经内分泌肿瘤的发病率很高，在转移性疾病发展之前通常是多发的。
Scand J Surg. 2021 Mar;110(1):44-50. doi: 10.1177/1457496919874484. Epub 2019 Oct 7.
5
Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤的腹膜转移
Ann Surg Oncol. 2017 Nov;24(12):3466-3468. doi: 10.1245/s10434-017-6055-4. Epub 2017 Aug 16.
6
[Diagnosis and treatment of the neuroendocrine tumors of the lung].[肺神经内分泌肿瘤的诊断与治疗]
Magy Onkol. 2018 Jul 20;62(2):113-118. Epub 2018 Apr 12.
7
Pancreatic neuroendocrine tumors: a review.胰腺神经内分泌肿瘤：综述
Future Oncol. 2015;11(5):853-64. doi: 10.2217/fon.14.285.
8
Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors.日本全国神经内分泌胃肠道肿瘤调查的初步结果。
J Gastroenterol. 2007 Jun;42(6):497-500. doi: 10.1007/s00535-007-2056-6. Epub 2007 Jun 29.
9
[Registry of neuroendocrine tumors (NET) in Czech Republic after three years of data collection].[捷克共和国神经内分泌肿瘤（NET）三年数据收集后的登记情况]
Klin Onkol. 2013;26(4):271-80. doi: 10.14735/amko2013271.
10
Incidence and Predictors of Second Primary Cancers in Patients With Neuroendocrine Tumors.神经内分泌肿瘤患者第二原发癌的发生率及预测因素。
JAMA Oncol. 2021 Nov 1;7(11):1718-1720. doi: 10.1001/jamaoncol.2021.4531.
引用本文的文献
1
Clinical characteristics and prognostic value of serological markers in pancreatic neuroendocrine tumors: a single-center retrospective study.胰腺神经内分泌肿瘤血清学标志物的临床特征及预后价值：一项单中心回顾性研究
Am J Cancer Res. 2025 Aug 15;15(8):3546-3556. doi: 10.62347/HTDK5833. eCollection 2025.
2
Current advances in neuroendocrine neoplasms of the colon and rectum.结肠和直肠神经内分泌肿瘤的当前进展
World J Clin Oncol. 2025 Aug 24;16(8):108906. doi: 10.5306/wjco.v16.i8.108906.
3
Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol.胃肠胰神经内分泌肿瘤患者病情进展后生长抑素类似物的持续使用（SAUNA试验）：一项随机对照试验方案
BMJ Open. 2025 Jul 3;15(7):e099996. doi: 10.1136/bmjopen-2025-099996.
4
Advances in Molecular Imaging for Neuroendocrine Neoplasms.神经内分泌肿瘤分子成像的进展
Cancers (Basel). 2025 Jun 17;17(12):2013. doi: 10.3390/cancers17122013.
5
Dynamic nomogram for predicting the overall survival and cancer-specific survival of patients with gastrointestinal neuroendocrine tumor: a SEER-based retrospective cohort study and external validation.预测胃肠道神经内分泌肿瘤患者总生存期和癌症特异性生存期的动态列线图：一项基于监测、流行病学和最终结果（SEER）数据库的回顾性队列研究及外部验证
Front Oncol. 2025 Jun 4;15:1594591. doi: 10.3389/fonc.2025.1594591. eCollection 2025.
6
Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from the All of Us Research Program.胃肠胰腺和肺神经内分泌肿瘤的相关危险因素：来自“我们所有人”研究项目的一项巢式病例对照研究
Cancer Epidemiol Biomarkers Prev. 2025 Aug 1;34(8):1395-1404. doi: 10.1158/1055-9965.EPI-25-0155.
7
A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties.一例肝移植患者神经内分泌肿瘤病例：诊断与管理难题
Life (Basel). 2025 Mar 7;15(3):421. doi: 10.3390/life15030421.
8
Improving neuroendocrine tumor treatments with mathematical modeling: lessons from other endocrine cancers.用数学建模改善神经内分泌肿瘤治疗：来自其他内分泌癌的经验教训。
Endocr Oncol. 2025 Feb 5;5(1):e240025. doi: 10.1530/EO-24-0025. eCollection 2025 Jan.
9
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.2024年神经内分泌肿瘤模型会议白皮书：神经内分泌肿瘤研究模型的现状与未来展望
Endocr Oncol. 2024 Dec 19;4(1):e240055. doi: 10.1530/EO-24-0055. eCollection 2024 Jan 1.
10
Construction and evaluation of the prediction model for advanced disease in well-differentiated colorectal neuroendocrine neoplasms less than 2 cm in diameter.直径小于2厘米的高分化结直肠神经内分泌肿瘤晚期疾病预测模型的构建与评估
Heliyon. 2024 Dec 13;11(1):e41197. doi: 10.1016/j.heliyon.2024.e41197. eCollection 2025 Jan 15.
本文引用的文献
1
Global burden of neuroendocrine tumors and changing incidence in Kentucky.肯塔基州神经内分泌肿瘤的全球负担及发病率变化
Oncotarget. 2018 Apr 10;9(27):19245-19254. doi: 10.18632/oncotarget.24983.
2
Patterns and Drivers of Costs for Neuroendocrine Tumor Care: A Comparative Population-Based Analysis.神经内分泌肿瘤治疗成本的模式和驱动因素：基于人群的比较分析。
Ann Surg Oncol. 2017 Oct;24(11):3312-3323. doi: 10.1245/s10434-017-5986-0. Epub 2017 Jul 10.
3
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
Zotero 插件